Market Cap (In USD)
5478.00
Revenue (In USD)
-
Net Income (In USD)
-
Avg. Volume
3254.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-5-0.1789
- PE
- -
- EPS
- -
- Beta Value
- -2.239
- ISIN
- US68235J2015
- CUSIP
- 68235J201
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. George Malesek
- Employee Count
- -
- Website
- https://www.oncology-pharma.com
- Ipo Date
- 1994-10-31
- Details
- Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
More Stocks
-
S32South32 Limited
S32
-
002350
-
300602
-
014530
-
3013
-
EROEro Copper Corp.
ERO
-
301211
-
FBU